Dr. Raymond Elsoueidi, MD

Dr. Elsoueidi practices at Hazard ARH Regional Medical Center in Hazard, Kentucky, part of ARH.

Dr. Elsoueidi's NPI, 1033348768, was assigned on July 2, 2009. Dr. Elsoueidi holds Kentucky license 42826.

Dr. Elsoueidi's primary practice is Hazard ARH Regional Medical Center, at 100 Medical Center Drive, Hazard, KY 41701 in Perry County. The practice phone is (606) 439-1331.

Dr. Elsoueidi's primary practice is Hazard ARH Regional Medical Center in Hazard, Kentucky, part of ARH. Dr. Elsoueidi is also affiliated with Highlands ARH Regional Medical Center. The medical group on file is ARH Pennington Gap Clinic. Dmand AI also links Dr. Elsoueidi to 1 more hospital, 1 rural health clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elsoueidi practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Elsoueidi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Elsoueidi is licensed in Kentucky.

CMS data shows 473 Medicare services from Dr. Elsoueidi across 8 procedure codes in 2024, for 186 Medicare patients. Medicare paid $26,529 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 186 Medicare patients who saw Dr. Elsoueidi in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elsoueidi's median patient age at 67, with 54% women.

In 2024, Dr. Elsoueidi wrote 1,670 Medicare Part D claims for 232 patients. 66% of them were for generic drugs. CMS names the drug for 1,354 of them, across 42 drugs with 11 or more claims each, at $4,407,232 in total drug cost. In 2023, CMS named 851 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Elsoueidi for performance year 2024, reported through an alternative payment model (APM). Dr. Elsoueidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Elsoueidi, published from 2014 to 2016. 2016 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Neoplasm Metastasis. Dr. Elsoueidi has published most often in J Oncol Pharm Pract. Dr. Elsoueidi's most frequent co-author is Elie M. Richa, MD.

CMS Open Payments shows 983 general payments to Dr. Elsoueidi from 72 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,725.